The Efficacy of Postoperative Application of HFNC at Acute Phase for Minimally Invasive Esophagectomy Surgery Patients

NACompletedINTERVENTIONAL
Enrollment

69

Participants

Timeline

Start Date

January 1, 2019

Primary Completion Date

November 30, 2020

Study Completion Date

November 30, 2021

Conditions
Esophageal Cancer
Interventions
DEVICE

High flow nasal cannula, HFNC

The HFNC used in this study can supply more than 40-60 L/min of oxygen flow, which is many times higher than the traditional nasal cannula. In addition, HFNC provides heating and moisturizing functions, so the patients 'nasal and oropharyngeal cavities do not dry out. This way, the patients can wear HFNC continuously for many days. Furthermore, when the patients close their mouths, HFNC can create a PEEP of 6-8 cmH2O, which helps with lung expansion after chest surgeries and lowers the risk of pneumonia related to lung collapses.

Trial Locations (1)

10048

National Taiwan University Hospital, Taipei

All Listed Sponsors
lead

National Taiwan University Hospital

OTHER

NCT03816748 - The Efficacy of Postoperative Application of HFNC at Acute Phase for Minimally Invasive Esophagectomy Surgery Patients | Biotech Hunter | Biotech Hunter